{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:11:48Z","timestamp":1762506708298,"version":"3.40.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.atherosclerosis.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T07:35:53Z","timestamp":1452756953000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-8855","authenticated-orcid":false,"given":"Lene R\u00f8rholm","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8114-365X","authenticated-orcid":false,"given":"Rasmus Huan","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Anholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary L.","family":"Walzem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mogens","family":"Fenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Bendix","family":"Haugaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib1","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/2047487312450228","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"19","author":"Perk","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0065-2423(08)00408-3","article-title":"Atherogenic lipoprotein subprofiling","volume":"46","author":"Ellington","year":"2008","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9149(02)02632-2","article-title":"Measurement issues related to lipoprotein heterogeneity","volume":"90","author":"Otvos","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib6","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0022-2275(20)31529-7","article-title":"Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity","volume":"42","author":"Pascot","year":"2001","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.ATV.17.6.1098","article-title":"Associations of HDL2 and HDL3 subfractions with Ischemic heart disease in men prospective results from the Qu\u00e9bec cardiovascular study","volume":"17","author":"Lamarche","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low-density lipoprotein particles as a predictor of the risk of Ischemic heart disease in men prospective results from the Qu\u00e9bec cardiovascular","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib10","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-\u03b1 and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the centers for disease control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib12","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy","volume":"286","author":"Lindmark","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib14","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.amjcard.2012.08.008","article-title":"Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention","volume":"110","author":"Lyngb\u00e6k","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2011.10.044","article-title":"The urokinase system in the pathogenesis of atherosclerosis","volume":"222","author":"Fuhrman","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/oby.2003.145","article-title":"Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers","volume":"11","author":"Pischon","year":"2003","journal-title":"Obes. Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2016.01.001_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/2047487314545280","article-title":"A\u00a0randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: the CUT-IT trial","volume":"22","author":"Pedersen","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib18","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib19","first-page":"977","article-title":"Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men","volume":"85","author":"Purnell","year":"2000","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2261-13-106","article-title":"Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol","volume":"13","author":"Pedersen","year":"2013","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib21","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1021\/ac2018124","article-title":"Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular disease","volume":"83","author":"Larner","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib22","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.1021\/ac0509657","article-title":"Metal ion complexes of EDTA as solutes for density gradient ultracentrifugation: influence of metal ions","volume":"77","author":"Johnson","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2015.03.118","article-title":"A\u00a0randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease","volume":"185","author":"Olsen","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.ATV.15.3.299","article-title":"Persistence of low HDL-c levels after weight reduction in older men with small LDL particles","author":"Katzel","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijcard.2012.01.008","article-title":"Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol","volume":"167","author":"Van de Woestijne","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","article-title":"Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol\/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healt","volume":"55","author":"Arsenault","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib27","doi-asserted-by":"crossref","first-page":"261878","DOI":"10.1155\/2014\/261878","article-title":"Validation of the friedewald formula in patients with metabolic syndrome","volume":"2014","author":"Knopfholz","year":"2014","journal-title":"Cholesterol"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-511X-5-8","article-title":"LDL cholesterol estimation in patients with the metabolic syndrome","volume":"5","author":"Gazi","year":"2006","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-511X-10-119","article-title":"Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults","volume":"10","author":"Varady","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM198811033191801","article-title":"Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise","volume":"319","author":"Wood","year":"1988","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1152\/ajpendo.90397.2008","article-title":"Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity","volume":"295","author":"Durheim","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib32","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa020194","article-title":"Effects of the amount and intensity of exercise on plasma lipoproteins","volume":"347","author":"Kraus","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archinte.164.1.31","article-title":"Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE\u2013a randomized controlled study","volume":"164","author":"Slentz","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-2007-964892","article-title":"LDL particle size in habitual exercisers, lean sedentary men and abdominally obese sedentary men","volume":"28","author":"O'donovan","year":"2007","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11883-004-0050-5","article-title":"Low-density lipoprotein particle number and risk for cardiovascular disease","volume":"6","author":"Cromwell","year":"2004","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib36","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1053\/euhj.2002.3239","article-title":"Combined endurance\/resistance training reduces plasma TNF-\u03b1 receptor levels in patients with chronic heart failure and coronary artery disease","volume":"23","author":"Conraads","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jacc.2003.10.041","article-title":"Reduction in C-reactive protein through cardiac rehabilitation and exercise training","volume":"43","author":"Milani","year":"2004","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2004.08.073","article-title":"Exercise training modulates cytokines activity in coronary heart disease patients","volume":"100","author":"Goldhammer","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2014.12.057","article-title":"Effect of exercise-based cardiac rehabilitation on arterial stiffness and inflammatory and endothelial dysfunction biomarkers: a randomized controlled trial of myocardial infarction patients","volume":"239","author":"Oliveira","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ahj.2006.04.019","article-title":"Response of high-sensitivity C-reactive protein to exercise training in an at-risk population","volume":"152","author":"Huffman","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/JIR.S54360","article-title":"High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease","volume":"7","author":"Mouridsen","year":"2014","journal-title":"J.\u00a0Inflamm. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s004210170002","article-title":"Markers of inflammation and myofibrillar proteins following eccentric exercise in humans","volume":"84","author":"MacIntyre","year":"2001","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archinte.167.1.31","article-title":"The effect of weight loss on c-reactive protein","volume":"167","author":"Selvin","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.metabol.2004.01.013","article-title":"Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic disease","volume":"53","author":"Browning","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/49.4.666","article-title":"Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation","volume":"49","author":"Rifai","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","article-title":"CRP and suPAR are differently related to anthropometry and subclinical organ damage","volume":"167","author":"Lyngb\u00e6k","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.001_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7754\/Clin.Lab.2012.120728","article-title":"Effects of acute exercise and allopurinol administration on soluble urokinase plasminogen activator receptor (suPAR)","volume":"59","author":"Sanchis-Gomar","year":"2013","journal-title":"Clin. Lab."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:56:02Z","timestamp":1654098962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016300016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":47,"alternative-id":["S0021915016300016"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.001","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}